Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Real-world optimization of antiviral regimens in entecavir-experienced adults with chronic hepatitis B
ChiCTR2100042089Phase 4Recruiting
- Sponsor
- Beijing YouAn Hospital
- Start
- Jan 2021
- Modality
- Small Molecules, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4, open-label trial of entecavir, tenofovir alafenamide and pegylated interferon alpha in Chronic Hepatitis B (CHB) (6 arms), sponsored by Beijing YouAn Hospital. Primary endpoint: HBV DNA. Started Jan 2021; status: recruiting.
02
Drugs
entecavirtenofovir alafenamidepegylated interferon alpha
03
Conditions
Chronic Hepatitis B (CHB)
Beyond the preview
Go deeper on ChiCTR2100042089.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2100042089.